The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 9th 2024
Remission according to the simplified definition correlated with the 2016 preliminary gout remission definition and GIS score improvements.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Study Tackles Tough Questions about Folic Acid Supplementation for Rheumatoid Arthritis
Although folic acid counteracts some of the negative side effects experienced by patients taking MTX to treat their rheumatoid arthritis, researchers have posited it may also reduce the effectiveness of MTX therapy. Several studies have suggested that this is indeed a possibility. A new study in Arthritis Research and Therapy sheds some light on this question.
Easing Chronic Lower Back Pain with… Words?
June 19th 2015With many Americans blaming overprescribing for the painkiller abuse epidemic, novel treatments excluding medication – such as the oxygen chamber – are few and far between. However, a new analysis may have uncovered one for patients with chronic lower back pain.
What a Clinical Research Review Tells Us-and What It Doesn't-About Knee Osteoarthritis Progression
Spend any appreciable time on PubMed, Medline, or Embase, and you can begin to think that there aren't many untapped areas of clinical exploration. Nothing could be further from the truth, of course, and a recent clinical review in Arthritis Research and Therapy outlines some of the uncharted territory even in a condition as prevalent as osteoarthritis of the knee.
Measuring Societal Value Placed on Rheumatoid Arthritis Treatments
Medical treatments and who pays for them-and how much they pay for them-are obviously widely divergent depending on the country's healthcare system. But whether a nation has universal coverage or a third-party payer system such as the one in the US, all systems try to draw some correlation between the cost and benefit of a given procedure or prescription therapy.
Many hospitals around the country are eliminating their paper records all together which is changing the way patient records are shared. This can have a long reach into a patient's life as different parts of their lives depend on having their records to send to various entities.
When converting medical records into an electronic form most of the work can be done without much consideration. However, when it comes to observations and other notes by healthcare professionals, how they are included and made available to patients can present the need for more in depth thought.
When given the choice of what parts of their records patients wanted made available to healthcare professionals, the results showed a mixed reaction to the ability. There were also questions raised about the risks associated with only making the records available to certain people.
Having one of the oldest electronic health record systems in the country the state of Indiana has been at the forefront of the field for close to 30 years. Using those records and networks in the state a group from the Regenstrief Institute looked at how patients might want to control who can see their records.
Your History of Viral Exposure Revealed
June 16th 2015The VirScan system can measure a subject's exposure to all known human viruses. This will enable population studies that find any associations with a particular viral infection for every rheumatological disease. And it only costs about $25 per blood sample.
Fatigue in Patients with Rheumatoid Arthritis: Don't Ask, Don't Tell?
June 12th 2015For decades researchers have been trying to identify the source of the correlation between rheumatoid arthritis (RA) and fatigue – a common symptom of the disease. However, the reason it may have remained a mystery for so long could be because there isn't one.
Attack on Generics' Price Escalates
Two more US senators have signed on to sponsor a bill addressing the rising prices of some generic drugs. The measure would penalize manufacturers when prices rise faster than inflation. The office of the US Inspector General for Health and Human Services also announced last week that it will soon begin a study of those increases.